Muscle radiodensity loss during cancer therapy is predictive for poor survival in advanced endometrial cancer.
Jie LeeJhen-Bin LinMeng-Hao WuYa-Ting JanChih-Long ChangChueh-Yi HuangFang-Ju SunYu-Jen ChenPublished in: Journal of cachexia, sarcopenia and muscle (2019)
Skeletal muscle radiodensity decreased significantly during treatment and was independently associated with poorer survival in patients with stage III endometrial cancer who underwent staging surgery and adjuvant chemoradiotherapy. SMD loss was occult and occurred independently of BMI change.
Keyphrases
- endometrial cancer
- skeletal muscle
- cancer therapy
- minimally invasive
- free survival
- insulin resistance
- early stage
- lymph node
- body mass index
- rectal cancer
- locally advanced
- pet ct
- type diabetes
- radiation therapy
- physical activity
- surgical site infection
- adipose tissue
- acute coronary syndrome
- atrial fibrillation
- percutaneous coronary intervention